Home › Lupus › Louisiana › New Orleans
Lupus clinical trials in New Orleans, LA
5 studies for Lupus are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50660, New Orleans
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- Ochsner Health System, New Orleans
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RecruitingPhase 3
- Research Site, New Orleans
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Tulane University Medical Center, New Orleans
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RecruitingPhase 2
- University Medical Center New Orleans, New Orleans
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Santa Monica, CA8 studies
- Oklahoma City, OK8 studies
- Boston, MA8 studies
- Los Angeles, CA8 studies
Other studies in New Orleans
- Breast Cancer12 studies
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Non-Small Cell Lung Cancer10 studies
- Prostate Cancer10 studies
- Lung Cancer9 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.